Error Augmentation for Upper Limb Rehabilitation in Stroke Survivors

NCT ID: NCT07039006

Last Updated: 2025-06-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

28 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-01-01

Study Completion Date

2025-05-29

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Stroke can severely limit a person's ability to move their arm, especially when trying to reach by extending the elbow. These challenges often persist long after the stroke and make everyday activities more difficult. The investigators are testing a feedback strategy called error augmentation (EA) feedback that intentionally exaggerates movement errors to promote motor learning.

In this study, the investigators designed a virtual reality training program that uses EA feedback to encourage people with chronic stroke to use more elbow extension during reaching. The EA feedback makes it appear as though the elbow is more bent than it actually is, prompting the participant to extend their elbow further than they normally would. By having the patient practice movement with enhanced feedback, the investigators predict that the patient will increase the range of motion and improve reaching ability.

This is a short, proof-of-concept study to evaluate whether EA feedback shows early promise for improving arm movement in people with upper limb motor impairment after stroke. Participants are randomly assigned to either an EA training group or a control group (no-EA feedback). Each person completes three 30-minute virtual reality training sessions over 1 week. The investigators assess arm movement and motor impairment before and after training, and again one hour after the training to determine if improvements are retained.

Findings from this preliminary study will help determine whether this EA-based training approach should be used in a longer 9-week clinical trial aimed at promoting long-term recovery of arm function after stroke.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Stroke

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Training with EA feedback

Subjects will undergo reaching training that includes EA feedback as a 30-degree elbow flexion error.

Group Type EXPERIMENTAL

Training with EA feedback

Intervention Type BEHAVIORAL

Subjects will undergo reaching training that includes a 30-degree elbow flexion error 3 times in 1 week.

Training without EA feedback

Subjects will undergo reaching training that does not include EA feedback.

Group Type SHAM_COMPARATOR

Training without EA feedback

Intervention Type BEHAVIORAL

Subjects will undergo reaching training that does not include EA feedback 3 times in 1 week.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Training with EA feedback

Subjects will undergo reaching training that includes a 30-degree elbow flexion error 3 times in 1 week.

Intervention Type BEHAVIORAL

Training without EA feedback

Subjects will undergo reaching training that does not include EA feedback 3 times in 1 week.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Sustained a first-ever cortical/sub-cortical ischemic/hemorrhagic stroke ≥6 mo and ≤5 yr previously
* Has no medical complications
* Has arm paresis but can voluntarily flex/extend the elbow \~30 degrees
* Can provide informed consent

Exclusion Criteria

* Has other major neurological or musculoskeletal problems that would interfere with task performance
* Has marked elbow proprioceptive deficits (\<6/12 Fugl-Meyer Assessment for the Upper-Limb (FMA-UL) Sensation Scale)
* Has visuospatial neglect (Line Bisection Test)
* Has uncorrected vision
* Has depression (\>14 on Beck Depression Inventory II)
Minimum Eligible Age

18 Years

Maximum Eligible Age

85 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

McGill University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Mindy F. Levin

Professor Mindy F. Levin

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Mindy F Levin, PT, PhD

Role: PRINCIPAL_INVESTIGATOR

School of Physical and Occupational Therapy, McGill University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Jewish Rehabilitation Hospital

Montreal, Quebec, Canada

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Canada

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol and Statistical Analysis Plan

View Document

Document Type: Informed Consent Form

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

MP-50-2020-1209

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Substrates for Post-Stroke Arm Rehabilitation
NCT06998485 NOT_YET_RECRUITING NA
Reaching in Stroke 3rd Phase
NCT02912923 COMPLETED NA